Greenlight Capital Re
GLRE · NASDAQ
About GLRE
- Employees
- 84
- Headquarters
- George Town
- Listed
- May 24, 2007
- Sector
- Financials
- Industry
- Insurance
- Website
- greenlightre.com
GLRE key statistics
- Market cap
- 492.88M
- Price-earnings ratio
- 10.48
- Dividend yield
- —
- Average volume
- 118.42K
- Volume
- 80.72K
- Open price
- $15.22
- High today
- $15.36
- Low today
- $15.03
- 52 Week high
- $19.39
- 52 Week low
- $11.57
Greenlight Capital Re (GLRE) at a glance
As of Oct 23, 2026, Greenlight Capital Re (GLRE) shares are priced at $15.10, giving the company a market cap of 492.88M and a price-to-earnings ratio of 10.48.
Today the stock has traded between $15.03 and $15.36. The current price is 0.5% above the day's low and 1.7% below its high.
Volume so far is 80.72K shares, below the average of 118.42K shares a day.
Over the past year Greenlight Capital Re has ranged from $11.57 to $19.39, and now sits 45% of the way up that range.
Greenlight Capital Re met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported -$0.89 per share against an estimate of -$0.3519.
GLRE earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 44.8% on average.
- Q3 FY24: reported $1.01 per share against an estimate of $0.663
- Q4 FY24: reported -$0.81 per share against an estimate of -$0.0204
- Q4 FY25: reported $1.44 per share against an estimate of $0.00
- Q1 FY25: reported $0.86 per share against an estimate of $0.51
- Q2 FY25: reported $0.01 per share against an estimate of -$0.357
- Q3 FY25: reported -$0.13 per share against an estimate of $0.204
- Q1 FY26: reported $1.05 per share against an estimate of $0.00
- Q2 FY26: reported -$0.89 per share against an estimate of -$0.3519
GLRE news
- Press releaseGlobe Newswire
- Press releaseGlobe Newswire
Greenlight Re Announces Financial Results for Second Quarter and Six Months Ended June 30, 2026
- Press releaseGlobe Newswire
Greenlight Innovation Syndicate 3456 Progresses to Full Lloyd’s Syndicate
- Press releaseGlobe Newswire
Greenlight Re Announces Financial Results for First Quarter March 31, 2026
- Press releaseGlobe Newswire
Greenlight Re Announces Financial Results for Fourth Quarter and Year-End December 31, 2025
- Press releaseBusiness Wire
AM Best Upgrades Credit Ratings of Greenlight Capital Re, Ltd. and Its Subsidiaries
- Press releaseGlobe Newswire
AM Best Upgrades Financial Strength Rating of Greenlight Reinsurance, Ltd. and Greenlight Reinsurance Ireland, DAC to "A" (Excellent)
- Press releaseGlobe Newswire
Greenlight Re Announces Financial Results for Third Quarter and Nine Months Ended September 30, 2025
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.